This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2021 Sep-Oct;53(5):415-416.

doi: 10.4103/ijp.ijp_406_21.

COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy

Ankit Bhardwaj¹, Vandana Roy²

Affiliations

Affiliations

¹ Department of Pharmacology, ABVIMS and Dr. RML Hospital, New Delhi, India.
² Department of Pharmacology, MAMC and LNJP Hospital, New Delhi, India.

PMID: 34854413
PMCID: PMC8641750
DOI: 10.4103/ijp.ijp_406_21

COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy

Ankit Bhardwaj et al. Indian J Pharmacol. 2021 Sep-Oct.

. 2021 Sep-Oct;53(5):415-416.

doi: 10.4103/ijp.ijp_406_21.

Authors

Ankit Bhardwaj¹, Vandana Roy²

Affiliations

¹ Department of Pharmacology, ABVIMS and Dr. RML Hospital, New Delhi, India.
² Department of Pharmacology, MAMC and LNJP Hospital, New Delhi, India.

PMID: 34854413
PMCID: PMC8641750
DOI: 10.4103/ijp.ijp_406_21

No abstract available

PubMed Disclaimer

Conflict of interest statement

None

Similar articles

Rhino-orbital-cerebral mucormycosis in COVID-19 patients - Taming the black evil with pharmacological weapons.
Kaur K, Gurnani B. Kaur K, et al. Indian J Pharmacol. 2021 Sep-Oct;53(5):417-419. doi: 10.4103/ijp.ijp_392_21. Indian J Pharmacol. 2021. PMID: 34854414 Free PMC article. No abstract available.
Implications of the second wave of COVID-19 in India.
Asrani P, Eapen MS, Hassan MI, Sohal SS. Asrani P, et al. Lancet Respir Med. 2021 Sep;9(9):e93-e94. doi: 10.1016/S2213-2600(21)00312-X. Epub 2021 Jun 30. Lancet Respir Med. 2021. PMID: 34216547 Free PMC article. No abstract available.
Lactoferrin, a potential iron-chelator as an adjunct treatment for mucormycosis - A comprehensive review.
Singh A, Ahmad N, Varadarajan A, Vikram N, Singh TP, Sharma S, Sharma P. Singh A, et al. Int J Biol Macromol. 2021 Sep 30;187:988-998. doi: 10.1016/j.ijbiomac.2021.07.156. Epub 2021 Jul 27. Int J Biol Macromol. 2021. PMID: 34324905 Review.
Update on mucormycosis pathogenesis.
Ibrahim AS, Kontoyiannis DP. Ibrahim AS, et al. Curr Opin Infect Dis. 2013 Dec;26(6):508-15. doi: 10.1097/QCO.0000000000000008. Curr Opin Infect Dis. 2013. PMID: 24126718 Free PMC article. Review.
Post-COVID-19 mucormycosis presenting as chest wall cellulitis with mediastinitis.
Arora N, Gudipati A, Kundu R, Prabhakar N, Suri V, Malhotra P, Jain A. Arora N, et al. Lancet Infect Dis. 2021 Nov;21(11):1611. doi: 10.1016/S1473-3099(21)00582-X. Lancet Infect Dis. 2021. PMID: 34717815 Free PMC article. No abstract available.

See all similar articles

Cited by

Antimycotic effect of 3-phenyllactic acid produced by probiotic bacterial isolates against Covid-19 associated mucormycosis causing fungi.
Lunavath R, Mohammad SH, Bhukya KK, Barigela A, Banoth C, Banothu AK, Bhukya B. Lunavath R, et al. PLoS One. 2023 Mar 30;18(3):e0279118. doi: 10.1371/journal.pone.0279118. eCollection 2023. PLoS One. 2023. PMID: 36996100 Free PMC article.

References

1. Kontoyiannis DP, Lewis RE. Invasive zygomycosis: Update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am. 2006;20:581–607. - PubMed
1. Ashourpour M, Djalali M, Djazayery A, Eshraghian MR, Taghdir M, Saedisomeolia A. Relationship between serum ferritin and inflammatory biomarkers with insulin resistance in a Persian population with Type 2 diabetes and healthy people. Int J Food Sci Nutr. 2010;61:316–23. - PubMed
1. Boelaert JR, Van Cutsem J, de Locht M, Schneider YJ, Crichton RR. Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect. Kidney Int. 1994;45:667–71. - PubMed
1. Gangadharan D, Sivaramakrishnan S, Pandey A, Madhavan Nampoothiri K. Folate-producing lactic acid bacteria from cow's milk with probiotic characteristics. Int J Dairy Technol. 2010;63:339–48.
1. Boelaert JR, de Locht M, Van Cutsem J, Kerrels V, Cantinieaux B, Verdonck A, et al. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest. 1993;91:1979–86. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information